|Articles|February 18, 2022
Supplements and Featured Publications
- Optimizing Outcomes in Multiple Sclerosis Through Individualized Treatment: Managed Care Considerations
Optimizing Outcomes in Multiple Sclerosis Through Individualized Treatment: Managed Care Considerations
Advertisement
This publication is sponsored by Novartis.
This Clinical Brief explores the economic impact of insurance-related barriers (eg, high cost-sharing for patients) and social determinants of health that result in differences in access to and utilization of health care in underserved populations with the objective of increasing awareness and understanding of these factors to facilitate positive outcomes in patients with multiple sclerosis.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
2
5 FAQs: Ebola Outbreaks and the Challenge of Public Trust
3
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
4
Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered
5
